Cargando…
Can small molecular inhibitors that stop de novo serine synthesis be used in cancer treatment?
To sustain their malignancy, tumour cells acquire several metabolic adaptations such as increased oxygen, glucose, glutamine, and lipids uptake. Other metabolic processes are also enhanced as part of tumour metabolic reprogramming, for example, increased serine metabolism. Serine is a non-essential...
Autores principales: | McNamee, Megan Jessica, Michod, David, Niklison-Chirou, Maria Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087698/ https://www.ncbi.nlm.nih.gov/pubmed/33931592 http://dx.doi.org/10.1038/s41420-021-00474-4 |
Ejemplares similares
-
The role of immunomodulators in treatment-resistant depression: case studies
por: Beckett, Charles W., et al.
Publicado: (2022) -
Glutamine metabolism, the Achilles heel for medulloblastoma tumor
por: Niklison-Chirou, Maria Victoria
Publicado: (2018) -
NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma
por: Frisira, Eleni, et al.
Publicado: (2019) -
Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation
por: Meier, Stefanie, et al.
Publicado: (2021) -
Proteasome inhibition—a new target for brain tumours
por: Rashid, Fatima, et al.
Publicado: (2019)